Suppr超能文献

变应原激活试验检测嗜碱性粒细胞在喹诺酮类药物超敏反应中的阴性结果:为激发试验决策提供了新突破。

Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decision-making.

机构信息

Immunology Laboratory, CHU Lyon-Sud, Pierre Bénite, France.

出版信息

Int Arch Allergy Immunol. 2012;157(3):299-302. doi: 10.1159/000328211. Epub 2011 Oct 31.

Abstract

BACKGROUND

Quinolone hypersensitivity reactions are being more frequently reported. Skin tests in investigations of patients are known to not be fully reliable. The provocation test thus remains the gold standard in the definitive diagnosis of allergy, despite the risks involved. The aim of this study was to evaluate basophil activation tests (BATs) in the diagnosis of immediate-type reactions to quinolones.

METHODS

Thirty-four patients who presented an immediate-type hypersensivity reaction less than an hour after quinolone administration were studied. The allergologic workup of these patients consisted of a careful clinical history, a skin test and a BAT with the culprit quinolone. If not contraindicated, and in the case of high probability of a nonallergic reaction, provocation tests were performed to assess the nonimmunologic nature of the hypersensitivity.

RESULTS

Among the 34 patients studied, 17 (50%) presented a negative BAT to the suspected quinolone, while the other 17 (50%) patients presented a positive BAT for quinolone at the time of their reaction. Among the 17 patients with negative BATs, 15 (2 of whom had had positive skin tests) had quinolone successfully reintroduced.

CONCLUSIONS

Our report suggests that the BAT, if negative for the culprit quinolone, is a valuable tool in the decision whether or not to perform provocation tests in patients with a history of immediate-type reaction to quinolones, in order to exclude an allergic reaction.

摘要

背景

喹诺酮类药物过敏反应的报告越来越多。已知在研究患者时,皮肤试验并不完全可靠。因此,尽管存在风险,激发试验仍然是过敏诊断的金标准。本研究旨在评估嗜碱性粒细胞激活试验(BAT)在诊断喹诺酮类药物即刻型反应中的作用。

方法

研究了 34 名在喹诺酮类药物给药后 1 小时内出现即刻型超敏反应的患者。这些患者的过敏检查包括仔细的临床病史、皮肤试验和与罪魁祸首喹诺酮的 BAT。如果没有禁忌症,并且高度怀疑非过敏反应,则进行激发试验以评估超敏反应的非免疫性质。

结果

在研究的 34 名患者中,17 名(50%)对可疑喹诺酮的 BAT 呈阴性,而其他 17 名(50%)患者在反应时对喹诺酮的 BAT 呈阳性。在 17 名 BAT 阴性的患者中,有 15 名(其中 2 名皮肤试验阳性)成功重新引入了喹诺酮。

结论

我们的报告表明,如果对罪魁祸首喹诺酮的 BAT 呈阴性,则在有喹诺酮即刻型反应史的患者中是否进行激发试验以排除过敏反应方面是一个有价值的工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验